Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

3 A-Rated Medical Stocks to Watch and Buy

The medical industry is set for significant growth due to technological advances, increased demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality healthcare. Therefore, it could be wise to buy fundamentally strong medical stocks GSK (GSK), National HealthCare (NHC), and MiMedx Group…

StockNews.com

What to know about January's annual drug price hikes

Spoiler: There are some decreases this year, too. Here's an overview of the changing prices and what to make of them.

WEKU

Exclusive: AAP govt procured drugs from 2 blacklisted pharma firms with many failed quality tests

Six drugs from six pharma firms have fuelled a tussle between the Centre and the Delhi government, with both sides trying to blame each other for substandard medicines making their way to the capital’s government hospitals.

Newslaundry

From analysis to the latest developments in health,
read the most diverse news in one place.

UK sets up critical imports council to protect vital supplies

Group will tackle potential restrictions to items such as medicine amid geopolitical and climate threats

The Guardian - UK

NHS Medicine Shortage Raises Concerns Over Patient Safety

There is a notable 100 per cent surge in medicine shortages compared to January 2022 as seen in the deteriorating health of patients across the UK.

International Business Times UK

3 Pharma Stocks for January 2024 Profits

The pharmaceutical industry is thriving, fueled by steady demand for drugs, cost-efficient alternative discoveries, and rapid technological innovations. Hence, fundamentally strong pharma stocks Novo Nordisk (NVO), Eton Pharmaceuticals (ETON), and Pacira BioSciences (PCRX) might be profitable buys now. Read on….

StockNews.com

Why is there a medicine shortage in the UK? Pharmacists urge political parties to prioritise issue

34 and 11 serious shortage protocols (SSPs) were issued in 2022 and 2023 respectively

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Synthetic opioids could fuel ‘second wave’ of UK drug deaths crisis, experts warn

Government urged to act as experts sound the alarm on nitazenes, with 54 deaths in past six months likely ‘tip of the iceberg’

The Independent UK

State Economics — Spotlight on New England: The Kiplinger Letter

After a better-than-expected 2023, New England states will see only modest employment growth in 2024.

Kiplinger

Are These 4 Biotech Stocks Worth Buying in 2024?

The need for innovative healthcare solutions, personalized medicines and treatments, and the use of advanced technologies will propel the biotech industry forward. Amid this backdrop, let’s explore the investment potential of biotech stocks TG Therapeutics (TGTX), Galapagos (GLPG), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR).

StockNews.com

Bayer undeterred by setback, forges ahead with US expansion

Bayer remains undeterred by setbacks as they forge ahead with plans to expand in the US market, showing resilience and determination in the face of challenges.

Top News

Merck Hooks Harpoon Therapeutics in 0M Acquisition Spree!

Merck sets sail into new therapeutic waters with the 0 million acquisition of Harpoon Therapeutics, harnessing the power of innovation to navigate treat...

Top News

Health Ministry notifies revised Pharma manufacturing rules under schedule M to ensure quality control

Revised Schedule M of Drugs and Cosmetics Rules, 1945 notified by Union Health Ministry to ensure robust quality control for pharma and biopharmaceutical products.

The Hindu

FDA allowing drug imports from Canada to lower prescription costs

Get the latest on the FDA's decision to allow Florida to import medications from Canada, potentially reducing prescription costs for Americans. Learn about...

Top News

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

US biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on China

Thermo Fisher, an American biotech company, has halted sales of its DNA testing products in Tibet, amid concerns that its products might have assisted the Chinese government in a surveillance campaign in the ethnic region

The Guardian - US

FDA approves program to allow Florida to import Canadian prescription drugs

State will be first to import drugs under federal program that Florida governor says could save consumers $150m in first year

Top News

FDA Approves Florida's Groundbreaking Prescription Drug Import Plan from Canada

FDA clears Florida's plan to import cheaper prescription drugs from Canada, marking a seismic shift in U.S. drug pricing and a win for consumers.

The Independent UK

Florida can import prescription drugs from Canada, US regulators say

Federal officials have cleared the way for Florida to begin importing cheaper prescription drugs from Canada

Get all your
news in one place.

100's of premium titles.
One news app.

Chicago Sun-Times

Weed dispensary plan at old Rainforest Cafe in River North goes up in smoke

Two lawsuits sought to block the joint venture between Progressive Treatment Solutions LLC and Bio-Pharm for an outlet at 605 N. Clark St.

Kiplinger

Drugmakers to Hike Prices on 500 Drugs Soon — Report

Big drugmakers plan to raise prices on more than 500 drugs this month, according to a Reuters report.

StockNews.com

3 Top-Rated Pharma Stock Picks to Consider in the New Year

The pharmaceutical industry is expected to grow rapidly due to rising global medical needs and technological advancements. With the industry expected to thrive in the coming years, it could be wise to buy Zoetis (ZTS), AstraZeneca (AZN) and Taro Pharmaceutical (TARO) for steady returns. Read more.

StockNews.com

Bullish or Bearish: 3 Pharma Options

The pharmaceutical industry’s robust outlook is driven by high healthcare spending globally, consistent R&D efforts, and the rapid adoption of advanced digital technologies. So, let’s analyze if investors should adopt a bullish or bearish stance on pharma stocks such as Tilray Brands (TLRY), CytomX Therapeutics (CTMX), and Wave Life Sciences…

The Independent UK

Consulting firm McKinsey agrees to $78 million settlement with insurers over opioids

Consulting firm McKinsey and Co. has agreed to pay $78 million to settle claims from insurers and health care funds that its marketing work with Purdue Pharma helped fuel an opioid addiction crisis

WEKU

How rock-bottom prices drive shortages of generic drugs used in hospitals

Hospitals rely on scores of generic drugs given by injection. But these workhorses are often in short supply. Cheap prices have led to factory closures that leave the supply chain vulnerable.

StockNews.com

3 Pharma Stock Buys for Last-Minute Year-End Profits

Growing healthcare spending and the use of cutting-edge technologies in the research and development of new drugs have put the pharmaceutical industry in a strong position for growth. With such constructive trends in mind, it's wise to buy fundamentally strong pharma stocks, Merck (MRK), Collegium (COLL) and Johnson & Johnson…

1 … 40 41 42 43

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.